Ayala Pharmaceuticals Inc (ADXS)

[knowenuftobedangerou]

Advaxis, Inc.
File No.1-36138 CF#34620
_____________________
Advaxis, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on January 9, 2017.
Based on representations by Advaxis, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:

Exhibit 10.57 through January 9, 2027
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority: